4.8 Article

Inhibition of the mammalian transcription factor LSF induces S-phase-dependent apoptosis by downregulating thymidylate synthase expression

Journal

EMBO JOURNAL
Volume 19, Issue 17, Pages 4665-4675

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/emboj/19.17.4665

Keywords

apoptosis; cell cycle progression; G(1)-S transition; LSF; thymidylate synthase

Funding

  1. NCI NIH HHS [T32 CA009361, CA81157, P30 CA016058, CA16058, CA38038, R01 CA081157-05, R01 CA081157] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [R01CA081157, P30CA016058, T32CA009361, R01CA038038] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The thymidylate synthase (TS) gene, which is induced at the G(1)-S transition in growth-stimulated cells, encodes an enzyme that is essential for DNA replication and cell survival. Here we demonstrate that LSF (LBP-1c, CP2) binds to sites within the TS promoter and intronic regions that are required for this induction. Mutation of the LSF binding sites inhibits G(1)-S induction of mRNA derived from a TS minigene, Furthermore, expression of dominant-negative LSF (LSFdn) prevents the increase in TS enzyme levels during G(1)-S, and induces apoptosis in growth-stimulated mouse and human cell lines. Such apoptosis can be prevented either by circumventing the TS requirement through addition of low concentrations of thymidine, or by coexpression of the TS gene driven by a heterologous promoter. Induction of apoptosis by LSFdn parallels the process known as thymineless death, which is induced by the TS inhibitor and chemotherapeutic drug 5-fluorodeoxyuridine. Thus, LSF is a novel regulatory factor that supports progression through S-phase by targeting a single gene that is critical for cell survival.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available